Suppr超能文献

河马信号通路在心脏发育、再生及疾病中的作用

The hippo pathway in heart development, regeneration, and diseases.

作者信息

Zhou Qi, Li Li, Zhao Bin, Guan Kun-Liang

机构信息

From the Life Sciences Institute, Innovation Center for Cell Signaling Network, Zhejiang University, Hangzhou, Zhejiang, China (Q.Z., B.Z.); Institute of Aging Research, Hangzhou Normal University, Hangzhou, Zhejiang, China (L.L.); and Department of Pharmacology and Moores Cancer Center, University of California at San Diego, La Jolla (K.-L.G.).

出版信息

Circ Res. 2015 Apr 10;116(8):1431-47. doi: 10.1161/CIRCRESAHA.116.303311.

Abstract

The heart is the first organ formed during mammalian development. A properly sized and functional heart is vital throughout the entire lifespan. Loss of cardiomyocytes because of injury or diseases leads to heart failure, which is a major cause of human morbidity and mortality. Unfortunately, regenerative potential of the adult heart is limited. The Hippo pathway is a recently identified signaling cascade that plays an evolutionarily conserved role in organ size control by inhibiting cell proliferation, promoting apoptosis, regulating fates of stem/progenitor cells, and in some circumstances, limiting cell size. Interestingly, research indicates a key role of this pathway in regulation of cardiomyocyte proliferation and heart size. Inactivation of the Hippo pathway or activation of its downstream effector, the Yes-associated protein transcription coactivator, improves cardiac regeneration. Several known upstream signals of the Hippo pathway such as mechanical stress, G-protein-coupled receptor signaling, and oxidative stress are known to play critical roles in cardiac physiology. In addition, Yes-associated protein has been shown to regulate cardiomyocyte fate through multiple transcriptional mechanisms. In this review, we summarize and discuss current findings on the roles and mechanisms of the Hippo pathway in heart development, injury, and regeneration.

摘要

心脏是哺乳动物发育过程中形成的首个器官。大小适宜且功能正常的心脏在整个生命周期中都至关重要。因损伤或疾病导致的心肌细胞丧失会引发心力衰竭,这是人类发病和死亡的主要原因。遗憾的是,成年心脏的再生潜力有限。Hippo信号通路是最近发现的一种信号级联反应,它通过抑制细胞增殖、促进细胞凋亡、调节干/祖细胞命运以及在某些情况下限制细胞大小,在器官大小控制中发挥着进化上保守的作用。有趣的是,研究表明该信号通路在心肌细胞增殖和心脏大小的调节中起关键作用。Hippo信号通路的几种已知上游信号,如机械应力、G蛋白偶联受体信号传导和氧化应激,在心脏生理学中发挥着关键作用。此外,Yes相关蛋白已被证明可通过多种转录机制调节心肌细胞命运。在本综述中,我们总结并讨论了目前关于Hippo信号通路在心脏发育、损伤和再生中的作用及机制的研究发现。

相似文献

1
The hippo pathway in heart development, regeneration, and diseases.
Circ Res. 2015 Apr 10;116(8):1431-47. doi: 10.1161/CIRCRESAHA.116.303311.
2
The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration.
Nat Rev Cardiol. 2018 Nov;15(11):672-684. doi: 10.1038/s41569-018-0063-3.
3
Harnessing Hippo in the heart: Hippo/Yap signaling and applications to heart regeneration and rejuvenation.
Stem Cell Res. 2014 Nov;13(3 Pt B):571-81. doi: 10.1016/j.scr.2014.04.010. Epub 2014 May 6.
4
Regulation of Myocardial Cell Growth and Death by the Hippo Pathway.
Circ J. 2016 Jun 24;80(7):1511-9. doi: 10.1253/circj.CJ-16-0476. Epub 2016 Jun 10.
6
Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size.
Science. 2011 Apr 22;332(6028):458-61. doi: 10.1126/science.1199010.
7
A growing role for the Hippo signaling pathway in the heart.
J Mol Med (Berl). 2017 May;95(5):465-472. doi: 10.1007/s00109-017-1525-5. Epub 2017 Mar 10.
8
Hippo pathway effector Yap promotes cardiac regeneration.
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13839-44. doi: 10.1073/pnas.1313192110. Epub 2013 Aug 5.
9
Upstream regulation of the Hippo-Yap pathway in cardiomyocyte regeneration.
Semin Cell Dev Biol. 2020 Apr;100:11-19. doi: 10.1016/j.semcdb.2019.09.004. Epub 2019 Oct 9.
10
Cardiomyocyte proliferation in cardiac development and regeneration: a guide to methodologies and interpretations.
Am J Physiol Heart Circ Physiol. 2015 Oct;309(8):H1237-50. doi: 10.1152/ajpheart.00559.2015. Epub 2015 Sep 4.

引用本文的文献

2
Cardiomyocyte YAP represses myocardial inflammation and fibrosis and restrains MEF2 regulated gene expression.
Am J Physiol Heart Circ Physiol. 2025 Jul 10. doi: 10.1152/ajpheart.00799.2024.
4
Hippo pathway activation mediates cardiomyocyte ferroptosis to promote dilated cardiomyopathy through downregulating NFS1.
Redox Biol. 2025 May;82:103597. doi: 10.1016/j.redox.2025.103597. Epub 2025 Mar 14.
5
UFMylation maintains YAP stability to promote vascular endothelial cell senescence.
iScience. 2025 Jan 21;28(2):111854. doi: 10.1016/j.isci.2025.111854. eCollection 2025 Feb 21.
7
The role of the extracellular matrix in cardiac regeneration.
Heliyon. 2024 Dec 17;11(1):e41157. doi: 10.1016/j.heliyon.2024.e41157. eCollection 2025 Jan 15.
8
The role of mechanosignaling in the control of myocardial mass.
Am J Physiol Heart Circ Physiol. 2025 Mar 1;328(3):H622-H638. doi: 10.1152/ajpheart.00277.2024. Epub 2024 Dec 31.
9
Spotlight on YAP: Unlocking New Insights to Overcome the Barriers to Heart Regeneration.
Circulation. 2025 Jan 7;151(1):94-97. doi: 10.1161/CIRCULATIONAHA.124.072263. Epub 2024 Dec 26.
10
The molecular mechanisms of cardiac development and related diseases.
Signal Transduct Target Ther. 2024 Dec 23;9(1):368. doi: 10.1038/s41392-024-02069-8.

本文引用的文献

1
Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival.
Circ Res. 2015 Jan 2;116(1):35-45. doi: 10.1161/CIRCRESAHA.115.304457. Epub 2014 Sep 23.
2
The alteration of Hippo/YAP signaling in the development of hypertrophic cardiomyopathy.
Basic Res Cardiol. 2014;109(5):435. doi: 10.1007/s00395-014-0435-8. Epub 2014 Aug 29.
3
Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model.
Circ Res. 2014 Jul 18;115(3):354-63. doi: 10.1161/CIRCRESAHA.115.303632. Epub 2014 May 15.
4
The Hippo transducer TAZ interacts with the SWI/SNF complex to regulate breast epithelial lineage commitment.
Cell Rep. 2014 Mar 27;6(6):1059-1072. doi: 10.1016/j.celrep.2014.02.038. Epub 2014 Mar 6.
6
Label-free quantitative proteomic analysis of the YAP/TAZ interactome.
Am J Physiol Cell Physiol. 2014 May 1;306(9):C805-18. doi: 10.1152/ajpcell.00339.2013. Epub 2014 Feb 26.
9
A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer.
Cancer Cell. 2014 Feb 10;25(2):166-80. doi: 10.1016/j.ccr.2014.01.010.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验